US 4,289,773 AGranted

Antiviral combinations

AssigneeEli Lilly and Company

InventorDonald C. DeLong

Life of this patent

Estimating the term…

Abstract

Antiviral combinations containing a 2-ester-substituted-3,4-dihydro-3-oxoquinoxaline and a hindered amine.

Claims1

Dependent claims

A method of suppressing influenza virus infections in mammals which comprises orally administering to a mammal exposed to influenza virus a virus-suppressing amount of a combination containing from 0.5-5 mg./kg. of ethyl 6,7-bromo-4-dihydro-3-oxoquinoxaline carboxylate and from 0.3-3 mg./kg. of 1-(1-adamantyl)-1-aminoethane.

Dependencies are inferred from the claim text.

Facts

Application: 06/206,748Filed 14 Nov 1980 · division
Priority: 18 Jun 1979
Granted: 15 Sep 1981
Term ends: Not estimatedThe source records don’t support an estimate.

Classification5 codes

C07D 241/52
With hetero atoms directly attached to ring nitrogen atoms: oxygen atoms
A61K 31/485
Quinolines; Isoquinolines: morphinan derivatives, e.g. morphine, codeine
C07D 241/44
Benzopyrazines: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or…
C07D
Heterocyclic compounds

Family

Serial49,671Parent of this division · filed 18 Jun 1979
Serial95,804Parent of this division · filed 19 Nov 1979
US 4,210,647 AParent of this division · filed 1 Jul 1980
US 4,289,773 AThis patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

Back to results